GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have moved well beyond diabetes management
10.1146/annurev-pharmtox-011112-140320 121 Mahmoud MoustafaE.RashedE
Research shows that GLP-1 response rates vary significantly between individualsup to 40% of patients may require alternative formulations or compounds to achieve their goals
BellomoRKellumJARoncoCWaldRMartenssonJMaidenMet al
00:02:15 Sara Klockars But now tirzepatide is approved for moderate to severe sleep apnea, and the thought is that tirzepatide, reduces weight, including the fat around the upper airway, which can lessen obstruction
[DOI] [PubMed] [Google Scholar] 211.Guo J., Russell E.G., Darcy R., Cotter T.G., McKenna S.L., Cahill M.R., ODriscoll C.M